Skip to main content
Veterinary Medicines

Furosoral10 mg tablets for dogs and cats

Authorised
  • Furosemide

Product identification

Medicine name:
Furosoral10 mg tablets for dogs and cats
Furosoral vet 10 mg tabletter til katt og hund
Active substance:
  • Furosemide
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Furosemide
    10.00
    milligram(s)
    /
    1.00
    Piece
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC03CA01
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • Cardboard box of 2 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 1 Aluminium-PVDC/PE/PVC blister with 10 tablets each, respectively corresponding to 10 tablets per box.
  • Cardboard box 3 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 30 tablets per box.
  • Cardboard box of 2 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 20 tablets per box.
  • Cardboard box of 100 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets.
  • Cardboard box of 4 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 3 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 1 Aluminium-PVDC/PVC blister with 10 tablets
  • Cardboard box of 10 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets.
  • Cardboard box of 6 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 50 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets.
  • Cardboard box of 5 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 9 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 8 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 7 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 25 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Artesan Pharma GmbH & Co. KG
  • Lelypharma B.V.
  • Genera d.d.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 14-10173
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0192/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 27/01/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 22/02/2023

Combined File of all Documents

English (PDF)
Published on: 22/01/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."